Literature DB >> 23302254

Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study.

H L Fisher1, A Caspi, R Poulton, M H Meier, R Houts, H Harrington, L Arseneault, T E Moffitt.   

Abstract

BACKGROUND: Childhood psychotic symptoms have been used as a subclinical phenotype of schizophrenia in etiological research and as a target for preventative interventions. However, recent studies have cast doubt on the specificity of these symptoms for schizophrenia, suggesting alternative outcomes such as anxiety and depression. Using a prospective longitudinal birth cohort we investigated whether childhood psychotic symptoms predicted a diagnosis of schizophrenia or other psychiatric disorders by 38 years of age.
METHOD: Participants were drawn from a birth cohort of 1037 children from Dunedin, New Zealand, who were followed prospectively to 38 years of age (96% retention rate). Structured clinical interviews were administered at age 11 to assess psychotic symptoms and study members underwent psychiatric assessments at ages 18, 21, 26, 32 and 38 to obtain past-year DSM-III-R/IV diagnoses and self-reports of attempted suicides since adolescence.
RESULTS: Psychotic symptoms at age 11 predicted elevated rates of research diagnoses of schizophrenia and posttraumatic stress disorder (PTSD) and also suicide attempts by age 38, even when controlling for gender, social class and childhood psychopathology. No significant associations were found for persistent anxiety, persistent depression, mania or persistent substance dependence. Very few of the children presenting with age-11 psychotic symptoms were free from disorder by age 38.
CONCLUSIONS: Childhood psychotic symptoms were not specific to a diagnosis of schizophrenia in adulthood and thus future studies of early symptoms should be cautious in extrapolating findings only to this clinical disorder. However, these symptoms may be useful as a marker of adult mental health problems more broadly.

Entities:  

Mesh:

Year:  2013        PMID: 23302254      PMCID: PMC3758773          DOI: 10.1017/S0033291712003091

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  29 in total

1.  Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk.

Authors:  Paolo Fusar-Poli; Ilaria Bonoldi; Alison R Yung; Stefan Borgwardt; Matthew J Kempton; Lucia Valmaggia; Francesco Barale; Edgardo Caverzasi; Philip McGuire
Journal:  Arch Gen Psychiatry       Date:  2012-03

2.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

Review 3.  Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies.

Authors:  I Kelleher; D Connor; M C Clarke; N Devlin; M Harley; M Cannon
Journal:  Psychol Med       Date:  2012-01-09       Impact factor: 7.723

4.  Posttraumatic stress disorder: anxiety or traumatic stress disorder?

Authors:  Patricia A Resick; Mark W Miller
Journal:  J Trauma Stress       Date:  2009-09-22

5.  'At-risk' for psychosis research: where are we heading?

Authors:  A Lin; B Nelson; A R Yung
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-30       Impact factor: 6.892

Review 6.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

7.  Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study.

Authors:  J Welham; J Scott; G Williams; J Najman; W Bor; M O'Callaghan; J McGrath
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

8.  DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population.

Authors:  J C Anderson; S Williams; R McGee; P A Silva
Journal:  Arch Gen Psychiatry       Date:  1987-01

9.  Mortality in first-contact psychosis patients in the U.K.: a cohort study.

Authors:  R Dutta; R M Murray; J Allardyce; P B Jones; J E Boydell
Journal:  Psychol Med       Date:  2011-12-13       Impact factor: 7.723

Review 10.  Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies.

Authors:  Filippo Varese; Feikje Smeets; Marjan Drukker; Ritsaert Lieverse; Tineke Lataster; Wolfgang Viechtbauer; John Read; Jim van Os; Richard P Bentall
Journal:  Schizophr Bull       Date:  2012-03-29       Impact factor: 9.306

View more
  98 in total

1.  Cognitive bias and unusual experiences in childhood.

Authors:  Nedah Hassanali; Tamatha Ruffell; Sophie Browning; Karen Bracegirdle; Catherine Ames; Richard Corrigall; Kristin R Laurens; Colette Hirsch; Elizabeth Kuipers; Lucy Maddox; Suzanne Jolley
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-14       Impact factor: 4.785

2.  Mental Health and Functional Outcomes in Young Adulthood of Children With Psychotic Symptoms: A Longitudinal Cohort Study.

Authors:  Antonella Trotta; Louise Arseneault; Avshalom Caspi; Terrie E Moffitt; Andrea Danese; Carmine Pariante; Helen L Fisher
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

3.  Disruptions in White Matter Maturation and Mediation of Cognitive Development in Youths on the Psychosis Spectrum.

Authors:  Catherine E Hegarty; Dietsje D Jolles; Eva Mennigen; Maria Jalbrzikowski; Carrie E Bearden; Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-12-27

Review 4.  Schizotypy from a developmental perspective.

Authors:  Martin Debbané; Neus Barrantes-Vidal
Journal:  Schizophr Bull       Date:  2014-12-29       Impact factor: 9.306

5.  Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study.

Authors:  Kathleen R Merikangas; Monica E Calkins; Marcy Burstein; Jian-Ping He; Rosetta Chiavacci; Tarannum Lateef; Kosha Ruparel; Ruben C Gur; Thomas Lehner; Hakon Hakonarson; Raquel E Gur
Journal:  Pediatrics       Date:  2015-03-09       Impact factor: 7.124

6.  Psychotic Experiences and Schizotypy in Early Adolescence Predict Subsequent Suicidal Ideation Trajectories and Suicide Attempt Outcomes From Age 18 to 38 Years.

Authors:  Kirstie J M O Hare; Richie Poulton; Richard J Linscott
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

7.  In the eye of the beholder: Perceptions of neighborhood adversity and psychotic experiences in adolescence.

Authors:  Joanne B Newbury; Louise Arseneault; Avshalom Caspi; Terrie E Moffitt; Candice L Odgers; Jessie R Baldwin; Helena M S Zavos; Helen L Fisher
Journal:  Dev Psychopathol       Date:  2017-12

8.  Advances and challenges in early intervention in psychosis.

Authors:  Ashok Malla; Jai Shah; Shalini Lal
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

9.  Moving interventions from after to before diagnosis.

Authors:  Iris E Sommer; Celso Arango
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

10.  Association Between Psychotic Experiences and Subsequent Suicidal Thoughts and Behaviors: A Cross-National Analysis From the World Health Organization World Mental Health Surveys.

Authors:  Evelyn J Bromet; Matthew K Nock; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Guilherme Borges; Ronny Bruffaerts; Louisa Degenhardt; Giovanni de Girolamo; Peter de Jonge; Silvia Florescu; Oye Gureje; Josep M Haro; Yanling He; Chiyi Hu; Elie G Karam; Viviane Kovess-Masfety; Sing Lee; Jean-Pierre Lepine; Zeina Mneimneh; Fernando Navarro-Mateu; Akin Ojagbemi; José Posada-Villa; Nancy A Sampson; Kate M Scott; Juan C Stagnaro; Maria C Viana; Miguel Xavier; Ronald C Kessler; John J McGrath
Journal:  JAMA Psychiatry       Date:  2017-11-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.